Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Double-Blind Trial of Sulforaphane for Therapeutic Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma

NCT07040280 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT07040280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07040280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Double-Blind Trial of Sulforaphane for Therapeutic Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Phase 2
Overall status
Recruiting
Start date
February 20, 2026
Completion date
March 1, 2033
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage 0 cutaneous melanoma ajcc v8, clinical stage i cutaneous melanoma ajcc v8, clinical stage ii cutaneous melanoma ajcc v8, clinical stage iii cutaneous melanoma ajcc v8, cutaneous dysplastic nevus